• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MCL-1在ATR介导的CHK1磷酸化过程中的关键作用。

An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation.

作者信息

Jamil Sarwat, Mojtabavi Shadi, Hojabrpour Payman, Cheah Stefanie, Duronio Vincent

机构信息

Department of Medicine, University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, BC, V6H 3Z6 Canada.

出版信息

Mol Biol Cell. 2008 Aug;19(8):3212-20. doi: 10.1091/mbc.e07-11-1171. Epub 2008 May 21.

DOI:10.1091/mbc.e07-11-1171
PMID:18495871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2488305/
Abstract

Here we report a novel role for myeloid cell leukemia 1 (Mcl-1), a Bcl-2 family member, in regulating phosphorylation and activation of DNA damage checkpoint kinase, Chk1. Increased expression of nuclear Mcl-1 and/or a previously reported short nuclear form of Mcl-1, snMcl-1, was observed in response to treatment with low concentrations of etoposide or low doses of UV irradiation. We showed that after etoposide treatment, Mcl-1 could coimmunoprecipitate with the regulatory kinase, Chk1. Chk1 is a known regulator of DNA damage response, and its phosphorylation is associated with activation of the kinase. Transient transfection with Mcl-1 resulted in an increase in the expression of phospho-Ser345 Chk1, in the absence of any evidence of DNA damage, and accumulation of cells in G2. Importantly, knockdown of Mcl-1 expression abolished Chk1 phosphorylation in response to DNA damage. Mcl-1 could induce Chk1 phosphorylation in ATM-negative (ataxia telangectasia mutated) cells, but this response was lost in ATR (AT mutated and Rad3 related)-defective cells. Low levels of UV treatment also caused transient increases in Mcl-1 levels and an ATR-dependent phosphorylation of Chk1. Together, our results strongly support an essential regulatory role for Mcl-1, perhaps acting as an adaptor protein, in controlling the ATR-mediated regulation of Chk1 phosphorylation.

摘要

我们在此报告Bcl-2家族成员髓样细胞白血病1(Mcl-1)在调节DNA损伤检查点激酶Chk1的磷酸化和激活方面的新作用。在用低浓度依托泊苷或低剂量紫外线照射处理后,观察到核Mcl-1和/或先前报道的Mcl-1短核形式snMcl-1的表达增加。我们发现,依托泊苷处理后,Mcl-1可与调节激酶Chk1进行共免疫沉淀。Chk1是已知的DNA损伤反应调节因子,其磷酸化与激酶的激活相关。在没有任何DNA损伤证据的情况下,用Mcl-1进行瞬时转染导致磷酸化的Ser345 Chk1表达增加,并且细胞在G2期积累。重要的是,敲低Mcl-1表达可消除DNA损伤时Chk1的磷酸化。Mcl-1可在ATM阴性(共济失调毛细血管扩张突变)细胞中诱导Chk1磷酸化,但在ATR(AT突变和Rad3相关)缺陷细胞中这种反应消失。低水平的紫外线处理也会导致Mcl-1水平短暂升高以及Chk1的ATR依赖性磷酸化。总之,我们的结果有力地支持了Mcl-1在控制ATR介导的Chk1磷酸化调节中起重要调节作用,可能作为衔接蛋白发挥作用。

相似文献

1
An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation.MCL-1在ATR介导的CHK1磷酸化过程中的关键作用。
Mol Biol Cell. 2008 Aug;19(8):3212-20. doi: 10.1091/mbc.e07-11-1171. Epub 2008 May 21.
2
ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response.ATM 依赖性表达的 IEX-1 控制 Mcl-1 的核积累和 DNA 损伤反应。
Cell Death Differ. 2010 Nov;17(11):1739-50. doi: 10.1038/cdd.2010.56. Epub 2010 May 14.
3
MCL-1 localizes to sites of DNA damage and regulates DNA damage response.MCL-1 定位于 DNA 损伤部位,并调节 DNA 损伤反应。
Cell Cycle. 2010 Jul 15;9(14):2843-55. doi: 10.4161/cc.9.14.12354. Epub 2010 Jul 11.
4
Ultrasound activates ataxia telangiectasia mutated- and rad3-related (ATR)-checkpoint kinase 1 (Chk1) pathway in human leukemia Jurkat cells.超声激活人白血病 Jurkat 细胞中的共济失调毛细血管扩张突变和 rad3 相关(ATR)检查点激酶 1(Chk1)通路。
Ultrason Sonochem. 2012 Nov;19(6):1246-51. doi: 10.1016/j.ultsonch.2012.04.003. Epub 2012 Apr 19.
5
Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.共济失调毛细血管扩张症突变基因(ATM)以及ATM和Rad3相关蛋白在应对不同形式的DNA损伤时表现出选择性的靶点特异性。
J Biol Chem. 2005 Jan 14;280(2):1186-92. doi: 10.1074/jbc.M410873200. Epub 2004 Nov 8.
6
Reconstitution of human claspin-mediated phosphorylation of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related) checkpoint kinase.由 ATR(共济失调毛细血管扩张症突变和 rad3 相关)检查点激酶重建人 claspin 介导的 Chk1 磷酸化。
J Biol Chem. 2009 Nov 27;284(48):33107-14. doi: 10.1074/jbc.M109.064485. Epub 2009 Oct 14.
7
Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.共济失调毛细血管扩张症突变基因(ATM)和NBS1依赖的Chk1蛋白丝氨酸317位点磷酸化对电离辐射的响应
J Biol Chem. 2003 Apr 25;278(17):14806-11. doi: 10.1074/jbc.M210862200. Epub 2003 Feb 14.
8
Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.有丝分裂 DNA 损伤反应:Polo 样激酶-1 通过 ATM-Chk1 途径去磷酸化。
Cell Cycle. 2010 Jun 15;9(12):2389-98. doi: 10.4161/cc.9.12.11904.
9
Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.MTA1 在 ATR 介导的 DNA 损伤检查点功能中的需求。
J Biol Chem. 2010 Jun 25;285(26):19802-12. doi: 10.1074/jbc.M109.085258. Epub 2010 Apr 28.
10
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1.Chk1的ATR磷酸化的2A型磷酸酶依赖性和非依赖性途径。
J Biol Chem. 2007 Mar 9;282(10):7287-98. doi: 10.1074/jbc.M607951200. Epub 2007 Jan 8.

引用本文的文献

1
MCL1 may not mediate chemoresistance.髓细胞白血病-1可能不介导化疗耐药。
bioRxiv. 2025 Aug 27:2025.08.22.671824. doi: 10.1101/2025.08.22.671824.
2
Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents.新型氰基嘧啶衍生物作为潜在的抗癌药物。
Molecules. 2025 Mar 25;30(7):1453. doi: 10.3390/molecules30071453.
3
Elevated expression drives esophageal squamous cell carcinoma stemness and induces resistance to radiotherapy.表达升高驱动食管鳞状细胞癌干性并诱导放疗抗性。
J Thorac Dis. 2024 Dec 31;16(12):8684-8698. doi: 10.21037/jtd-2024-2027. Epub 2024 Dec 28.
4
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.高三尖杉酯碱通过调节p38丝裂原活化蛋白激酶/H2AX/髓细胞白血病-1轴增强阿糖胞苷诱导的急性髓系白血病细胞凋亡。
BMC Cancer. 2024 Apr 24;24(1):520. doi: 10.1186/s12885-024-12286-7.
5
Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 Synergizes with Cisplatin in Triple-Negative Breast Cancer.髓系细胞白血病1小分子抑制剂S63845与顺铂在三阴性乳腺癌中协同作用。
Cancers (Basel). 2023 Sep 8;15(18):4481. doi: 10.3390/cancers15184481.
6
Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: Implications for hepatocellular carcinoma.小鼠肝脏中Mcl-1缺乏导致核多倍体化和有丝分裂错误:对肝细胞癌的影响。
JHEP Rep. 2023 Jul 11;5(10):100838. doi: 10.1016/j.jhepr.2023.100838. eCollection 2023 Oct.
7
Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it.髓系细胞白血病-1:抗癌治疗的巨大障碍以及对其进行靶向治疗的探索
Explor Target Antitumor Ther. 2022;3(3):278-296. doi: 10.37349/etat.2022.00083. Epub 2022 May 24.
8
Targeting cancer stemness mediated by BMI1 and MCL1 for non-small cell lung cancer treatment.针对非小细胞肺癌中 BMI1 和 MCL1 介导的癌症干细胞特性的治疗策略。
J Cell Mol Med. 2022 Aug;26(15):4305-4321. doi: 10.1111/jcmm.17453. Epub 2022 Jul 6.
9
Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.青蒿琥酯通过调控 Noxa/Bim/Mcl-1/p-Chk1 轴增强 venetoclax 联合阿糖胞苷靶向 AML 细胞的作用。
Cell Death Dis. 2022 Apr 20;13(4):379. doi: 10.1038/s41419-022-04810-z.
10
Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanism.西达本胺与维奈克拉对急性髓系白血病细胞凋亡的协同作用及其机制
Ann Transl Med. 2021 Oct;9(20):1575. doi: 10.21037/atm-21-5066.

本文引用的文献

1
Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway.Bcl2通过非同源末端连接途径对DNA双链断裂修复起负调控作用。
Mol Cell. 2008 Feb 29;29(4):488-98. doi: 10.1016/j.molcel.2007.12.029.
2
The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function.抗凋亡BCL-2同源物MCL-1的N末端调节其定位和功能。
J Biol Chem. 2007 Nov 2;282(44):32233-42. doi: 10.1074/jbc.M706408200. Epub 2007 Sep 6.
3
Linking PCNA-dependent replication and ATR by human Claspin.人类Claspin将增殖细胞核抗原(PCNA)依赖的复制与共济失调毛细血管扩张症突变基因(ATR)联系起来。
Biochem Biophys Res Commun. 2007 Mar 23;354(4):1028-33. doi: 10.1016/j.bbrc.2007.01.091. Epub 2007 Jan 25.
4
Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.髓细胞白血病序列-1(Mcl-1)与截短的Bid相互作用,并抑制其诱导的细胞色素c释放及其在受体介导的细胞凋亡中的作用。
J Biol Chem. 2006 Mar 3;281(9):5750-9. doi: 10.1074/jbc.M505688200. Epub 2005 Dec 27.
5
Proapoptotic BID is an ATM effector in the DNA-damage response.促凋亡蛋白BID是DNA损伤反应中的一种ATM效应蛋白。
Cell. 2005 Aug 26;122(4):593-603. doi: 10.1016/j.cell.2005.06.014.
6
A role for proapoptotic BID in the DNA-damage response.促凋亡蛋白BID在DNA损伤反应中的作用。
Cell. 2005 Aug 26;122(4):579-91. doi: 10.1016/j.cell.2005.06.022.
7
Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.造血细胞因子通过Akt/GSK3途径增强依托泊苷对Chk1依赖性G2/M期检查点的激活作用,从而抑制细胞凋亡。
Oncogene. 2005 Mar 17;24(12):1973-81. doi: 10.1038/sj.onc.1208408.
8
Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity.Bcl-2表达通过抑制E2F转录活性来抑制错配修复活性。
Nat Cell Biol. 2005 Feb;7(2):137-47. doi: 10.1038/ncb1215. Epub 2004 Dec 26.
9
A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1.Mcl-1的一个蛋白水解片段表现出核定位,并通过与Cdk1相互作用来调节细胞生长。
Biochem J. 2005 May 1;387(Pt 3):659-67. doi: 10.1042/BJ20041596.
10
Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.塞克尔综合征表现出细胞特征,显示ATR信号通路存在缺陷。
Hum Mol Genet. 2004 Dec 15;13(24):3127-38. doi: 10.1093/hmg/ddh335. Epub 2004 Oct 20.